IBIO iBio, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

IBIO [AMEX]

iBio, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	1.20%	Shs Outstand	143.88M	Perf Week	-3.00%
Market Cap	667.60M	Forward P/E	-	EPS next Y	-	Insider Trans	-7.11%	Shs Float	109.49M	Perf Month	130.61%
Income	-39.20M	PEG	-	EPS next Q	-	Inst Own	8.50%	Short Float	2.69%	Perf Quarter	318.52%
Sales	1.30M	P/S	513.54	EPS this Y	38.70%	Inst Trans	2.83%	Short Ratio	0.12	Perf Half Y	1561.76%
Book/sh	0.05	P/B	90.40	EPS next Y	-	ROA	-108.70%	Target Price	-	Perf Year	545.71%
Cash/sh	0.07	P/C	66.76	EPS next 5Y	-	ROE	-	52W Range	0.05 - 7.45	Perf YTD	1715.26%
Dividend	-	P/FCF	-	EPS past 5Y	-10.10%	ROI	-57.60%	52W High	-39.33%	Beta	-5.51
Dividend %	-	Quick Ratio	1.70	Sales past 5Y	58.00%	Gross Margin	-	52W Low	8940.00%	ATR	0.78
Employees	7	Current Ratio	1.70	Sales Q/Q	-80.00%	Oper. Margin	-	RSI (14)	57.39	Volatility	16.21% 19.53%
Optionable	Yes	Debt/Eq	8.40	EPS Q/Q	73.40%	Profit Margin	-	Rel Volume	0.39	Prev Close	4.44
Shortable	Yes	LT Debt/Eq	8.03	Earnings	-	Payout	-	Avg Volume	25.15M	Price	4.52
Recom	-	SMA20	15.44%	SMA50	76.82%	SMA200	302.72%	Volume	9,769,399	Change	1.80%

Jun-26-20

Initiated

Alliance Global Partners

Buy

$2.55

Jul-20-20 10:17AM	IBio's stock soars, but Novavax and Inovio stocks fall amid news on other COVID-19 vaccine candidates MarketWatch +63.94%
Jul-10-20 03:19PM	A Safer Way to Play IBio Stock Could Spread Like the Coronavirus InvestorPlace
11:24AM	3 Reasons to Invest in, Not Trade iBio InvestorPlace
Jul-02-20 01:56PM	Why iBio Is an Excellent Pandemic Spec Play InvestorPlace -5.77%
Jun-27-20 11:55AM	Coronavirus update: U.S. sets another record for new cases and some states scramble to revisit their reopening plans MarketWatch
Jun-26-20 02:32PM	Coronavirus update: U.S. sets record for new cases in a single day, as Texas becomes first state to reimpose restrictions MarketWatch +33.54%
11:48AM	iBio Is in a Healthy Position With Covid-19 Vaccine Push InvestorPlace
08:18AM	IBio's stock rockets on heavy volume after Russell index inclusion MarketWatch
06:45AM	iBio to be Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire
Jun-24-20 06:45AM	iBio Selected by IBM Watson Health for the use of IBM Clinical Development Solution at No Cost to help Support clinical COVID-19 Vaccine Candidates GlobeNewswire +6.90%
Jun-18-20 10:50PM	As Insiders Cash Out, Its Time to Sell Moderna Stock InvestorPlace
Jun-05-20 06:01AM	For iBio, the Coronavirus Pandemic Was a Lucky Break InvestorPlace -8.28%
Jun-04-20 07:00AM	iBio Announces Second COVID-19 Vaccine Program GlobeNewswire +8.33%
May-29-20 09:10AM	Slim Vaccine Chances Make iBio Stock Too Speculative Here InvestorPlace
May-27-20 11:45AM	Hedge Funds Have Never Been This Bullish On iBio, Inc. (IBIO) Insider Monkey
May-22-20 09:05AM	7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine InvestorPlace
May-21-20 02:44PM	6 Top-Rated Stocks for a Post-Coronavirus-Crisis Bump InvestorPlace +5.07%
Apr-28-20 03:44PM	Why iBio's Stock Is Trading Higher Today Benzinga +22.26%
Apr-27-20 04:15PM	iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility GlobeNewswire
Apr-24-20 07:00AM	The Coronavirus Makes iBio Finally Relevant InvestorPlace -5.25%
Apr-09-20 07:30AM	iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute GlobeNewswire +6.61%
Apr-03-20 05:01AM	IBIO Stock Will Continue to Slide Lower After Speculative COVID-19 Surge InvestorPlace -9.22%
Mar-26-20 04:20PM	iBio Supporting AzarGen Biotechnologies Development of a Rituximab Biosimilar GlobeNewswire +7.14%
07:30AM	iBio Announces Advancement of COVID-19 Vaccine Program GlobeNewswire
Mar-20-20 11:38AM	Dont Waste Time and Risk Capital on Coronavirus Play IBIO Stock InvestorPlace
07:30AM	iBio Joins the Alliance for Biosecurity GlobeNewswire
Mar-18-20 08:00AM	iBio Announces Development of Proprietary COVID-19 Vaccine Candidates GlobeNewswire +40.35%
Mar-13-20 08:08AM	iBio Stock Is Unlikely a Coronavirus Winner and Thus a Real Gamble InvestorPlace +11.89%
Mar-12-20 04:45PM	iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO GlobeNewswire -9.49%
Mar-05-20 04:20PM	Dow notches another 900-point loss as benchmark government bond carves out new record low MarketWatch
08:07AM	iBio stock surges 19% premarket on hopes for plans to develop plant-based coronavirus vaccine MarketWatch
Mar-02-20 04:30PM	iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split GlobeNewswire -9.80%
Feb-28-20 10:12AM	iBio shares soar another 174% on hopes for China vaccine partnership MarketWatch +183.24%
Feb-17-20 08:52AM	Here's Why iBio (NYSEMKT:IBIO) Must Play Its Cards Just Right Simply Wall St.
Feb-06-20 04:30PM	iBio, Inc. Announces Postponement of Annual Meeting GlobeNewswire
Feb-04-20 08:54AM	Benzinga Pro's Top 5 Stocks To Watch For Tues., Feb. 4, 2020: GOOGL, DIS, EBAY, F, IBIO Benzinga +61.69%
Feb-03-20 04:15PM	iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine GlobeNewswire
Jan-16-20 08:00AM	iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance GlobeNewswire +8.52%
Jan-06-20 09:15AM	iBio Initiates New Litigation Against Fraunhofer GlobeNewswire -11.39%
Dec-23-19 09:30AM	EdgePoint announces collaboration with iBio CDMO to implement AI/Blockchain driven TrustPoint Vision Technology in its Texas cGMP facility GlobeNewswire -9.26%
08:30AM	iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing GlobeNewswire
Dec-19-19 11:22AM	Is iBio, Inc.'s (NYSEMKT:IBIO) CEO Being Overpaid? Simply Wall St.
Dec-16-19 04:15PM	iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming GlobeNewswire -12.89%
Dec-13-19 05:00PM	iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire -7.98%
Dec-10-19 04:44PM	iBio Introduces FastGlycaneering Development Service to Power Recombinant Protein Production GlobeNewswire -9.39%
Dec-03-19 12:31PM	iBio Joins Manufacturing USAs Tissue Biofabrication Initiative GlobeNewswire +41.35%
Dec-02-19 04:15PM	iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference GlobeNewswire +20.04%
Oct-25-19 08:30AM	iBio, Inc. Prices $5,000,000 Public Offering GlobeNewswire -43.26%
Oct-22-19 04:30PM	iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire +15.10%
Sep-19-19 01:58PM	One Thing To Remember About The iBio, Inc. (NYSEMKT:IBIO) Share Price Simply Wall St.
Sep-17-19 04:15PM	iBios Collaboration with South Africas AzarGen Biotechnologies Advances to Next Stage GlobeNewswire
Aug-26-19 05:30PM	iBio and CC-Pharming Expand Business Collaboration in China GlobeNewswire -7.43%
Aug-21-19 12:15PM	A Look At Benzinga Pro's Most-Searched Tickers For August 21, 2019 Benzinga -7.87%
Aug-19-19 04:35PM	iBio Inks 3D Bioprinting Agreement GlobeNewswire
Jul-25-19 11:16AM	Did Changing Sentiment Drive iBio's (NYSEMKT:IBIO) Share Price Down A Painful 89%? Simply Wall St.
Jun-19-19 08:00AM	iBio Announces First Agreement for Fill-Finish Services GlobeNewswire
Jun-10-19 01:58PM	How Should Investors React To iBio, Inc.'s (NYSEMKT:IBIO) CEO Pay? Simply Wall St.
Jun-03-19 08:00AM	iBio Launches New Sterile Fill-Finish Services GlobeNewswire
Apr-24-19 02:03PM	What Type Of Shareholder Owns iBio, Inc.'s (NYSEMKT:IBIO)? Simply Wall St.
Apr-01-19 08:30AM	iBio Announces Appointment of Thomas F. Isett to Board of Directors GlobeNewswire
Dec-14-18 08:00AM	iBio Provides Status Update on its Continuing Litigation Against Fraunhofer GlobeNewswire
Dec-03-18 08:00AM	iBio to Present at Brazilian Ministry of Healths Plant-Made Pharmaceutical Meeting GlobeNewswire
Oct-02-18 08:00AM	iBio and CC-Pharming Hold First Design and Strategy Meeting GlobeNewswire +13.53%
Aug-22-18 04:10PM	iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance GlobeNewswire
Jul-09-18 08:00AM	iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China GlobeNewswire +8.00%
Jun-27-18 07:20AM	Free Technical Research on Nektar Therapeutics and Three More Biotech Equities ACCESSWIRE
Jun-26-18 06:59PM	iBio, Inc. Closes $16,000,000 Public Offering GlobeNewswire
Jun-22-18 07:26AM	iBio, Inc. Prices $16,000,000 Public Offering GlobeNewswire
Jun-08-18 04:30PM	iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split GlobeNewswire
04:01PM	iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire
Jun-05-18 08:30AM	iBio and ONEWAY Diagnostica Develop New Products for Brazil GlobeNewswire +10.21%
Jun-04-18 05:46PM	Why iBio Incs (NYSEMKT:IBIO) Ownership Structure Is Important Simply Wall St.
May-31-18 08:30AM	iBio, Inc. Announces Reverse Stock Split GlobeNewswire -7.40%
May-24-18 07:15AM	Complimentary Technical Snapshots on Heat Biologics and Three More Biotech Stocks ACCESSWIRE
Apr-11-18 01:27PM	Should iBio Incs (NYSEMKT:IBIO) Recent Earnings Decline Worry You? Simply Wall St. -9.57%
Mar-14-18 08:30AM	iBio Selects Lead Candidate for its Fibrosis Therapeutics Program GlobeNewswire
Mar-12-18 08:30AM	iBio Patent Issues in China on Protein Glycosylation Modification GlobeNewswire
Mar-07-18 08:45AM	iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics GlobeNewswire +26.09%
Dec-18-17 03:44PM	ETFs with exposure to iBio, Inc. : December 18, 2017 Capital Cube +5.91%
Dec-08-17 02:53PM	iBio Inc (IBIO): Does -31.1% EPS Decline Lately Make It An Underperformer? Simply Wall St.
01:03PM	ETFs with exposure to iBio, Inc. : December 8, 2017 Capital Cube
Nov-30-17 04:15PM	iBio, Inc. Closes $4,500,000 Offering of Common Stock GlobeNewswire
Nov-29-17 09:00AM	iBio, Inc. Prices $4,500,000 Firm Commitment Offering of Common Stock GlobeNewswire -31.61%
Nov-28-17 05:07PM	iBio, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-27-17 02:12PM	ETFs with exposure to iBio, Inc. : November 27, 2017 Capital Cube
Nov-14-17 02:27PM	ETFs with exposure to iBio, Inc. : November 14, 2017 Capital Cube
Nov-13-17 09:20AM	iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2018 By the Numbers : November 13, 2017 Capital Cube
Nov-08-17 12:00PM	AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research
Nov-06-17 05:00PM	iBio, Inc. Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court GlobeNewswire
Oct-30-17 08:30AM	iBio CDMO President to Co-Chair South African Molecular Pharming Conference GlobeNewswire
Oct-24-17 09:39AM	ETFs with exposure to iBio, Inc. : October 24, 2017 Capital Cube -5.51%
Oct-23-17 08:00AM	IBio, Aethlon Agreement, The Biologics Market, and Analysts Target, CFB-03 Update ACCESSWIRE
Oct-18-17 07:00AM	Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE
Oct-16-17 07:15AM	iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire
07:15AM	Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire
Oct-13-17 10:56AM	ETFs with exposure to iBio, Inc. : October 13, 2017 Capital Cube
Oct-05-17 05:36PM	What Are The Drivers Of iBio Incs (IBIO) Risks? Simply Wall St.
Oct-04-17 09:00AM	iBio, Inc. :IBIO-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017 Capital Cube
Oct-02-17 10:54AM	ETFs with exposure to iBio, Inc. : October 2, 2017 Capital Cube
08:30AM	iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development GlobeNewswire

iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of pre-clinical development, regulatory approval, commercial product launch, and on-going commercial phase requirements. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. The company is also developing vaccine candidates for third parties. It has a license agreement with the University of Natural Resources and Life Sciences, Vienna; a strategic relationship with Beijing CC-Pharming Ltd.; and collaboration agreements with AzarGen Biotechnologies (Pty) Ltd, The Texas A&M University System, and Fraunhofer Center for Molecular Biotechnology. In addition, the company offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ERWIN ROBERT L	President	Jun 04	Option Exercise	0.93	28,268	26,289	108,108	Jun 08 12:41 PM
ERWIN ROBERT L	President	Jun 04	Sale	1.71	28,268	48,338	108,108	Jun 08 12:41 PM
ERWIN ROBERT L	President	Jun 02	Option Exercise	0.93	96,124	89,395	136,376	Jun 05 06:04 AM
ERWIN ROBERT L	President	Jun 02	Sale	1.62	96,124	155,721	136,376	Jun 05 06:04 AM
Mullaney James P.	Chief Financial Officer	May 27	Option Exercise	0.93	11,250	10,463	0	May 29 12:45 PM
Mullaney James P.	Chief Financial Officer	May 27	Sale	1.61	11,250	18,113	0	May 29 12:45 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience